Yang, L., Li, D., Sun, S., Liu, D., Wang, Y., Liu, X., . . . Tao, J. (2024). Dupilumab therapy improves gut microbiome dysbiosis and tryptophan metabolism in Chinese patients with atopic dermatitis. International immunopharmacology, 131, 111867. https://doi.org/10.1016/j.intimp.2024.111867
Chicago Style (17th ed.) CitationYang, Liu, et al. "Dupilumab Therapy Improves Gut Microbiome Dysbiosis and Tryptophan Metabolism in Chinese Patients with Atopic Dermatitis." International Immunopharmacology 131 (2024): 111867. https://doi.org/10.1016/j.intimp.2024.111867.
MLA (9th ed.) CitationYang, Liu, et al. "Dupilumab Therapy Improves Gut Microbiome Dysbiosis and Tryptophan Metabolism in Chinese Patients with Atopic Dermatitis." International Immunopharmacology, vol. 131, 2024, p. 111867, https://doi.org/10.1016/j.intimp.2024.111867.